Clinical Trial Update: Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase 1/2 study of Yttrium-90 radioembolization in combination with nivolumab for liver and extrahepatic metastases from meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Yttrium-90 radioembolization (yttrium-90 microspheres)
• nivolumab (nivolumab)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: WITHDRAWN